Haven Tower’s Post

Itaconix (AIM:ITX, OTCQB:ITXXF) CEO John Shaw takes Proactive's Stephen Gunnion through the company's half-year trading update and its strategic initiatives for the future. Shaw highlighted the company’s positive first half, with notable improvements in gross profit margins despite a decline in revenue. He explained, "We had $2.8 million in revenue versus $4 million in the first half of 2023," attributing this to strategic decisions made in March and April aimed at diversifying revenue and increasing profit margins. Watch at #Proactive #ProactiveInvestors http://ow.ly/CrVJ105BPK4

The UK real estate market presents a wealth of opportunities for those looking to invest and grow their business. Investing in real estate not only enhances your portfolio but also positions your company for long-term success. At RXCO, we provide valuable insights and resources to help you navigate this evolving landscape. Explore our pages to discover expert advice, growth analysis, and investment strategies tailored for your #business. Visit RXCO today and start maximizing your potential! #RealEstateUK #BusinessGrowth #RXCO #MarketInsights #PropertyInvestment #UKProperty #RealEstateInvesting #Web3 #decentralizedfinance #Fintech

Very exciting news from Immunic: This morning, we announced a three-tranche private placement of up to $240 million. The financing is being led by BVF Partners, and includes participation from new and existing investors, including Avidity Partners, Janus Henderson Investors, Soleus Capital, RTW Investments and Adage Capital Partners. The proceeds from the first tranche are expected to extend our cash runway into Q3/2025. In a second announcement this morning, we highlighted our 2023 accomplishments and upcoming milestones. Read more here: https://bit.ly/3S6napz and here: https://bit.ly/3NRg4Tq. #IMUX #Immunic #financing #investors #accomplishments #milestones

The proxy fight between Masimo and Politan Capital Management continues to heat up ahead of the #digitalhealth pioneer’s July 25 shareholders meeting. Check out the latest developments below. #medtech #meddevice

Tactical Alpha Strategy | Chop Suey - Justin Collazo Maybe a semis resurgence comes at the expense of software (IGV), which has outperformed semis since mid-June. The DeMark combo 13 sell marked the high for the ratio in June, and the recent combo 13 buy appeared near the lows; now the DTL has been pierced. We think semis will continue to outperform. Read full story here: https://buff.ly/4ejWDOi For more information on our #tactical #alpha #strategy product, and other Aletheia Capital research, please contact info@aletheia-capital.com #investments #advisory #ideas #fintech #InYourCorner

We have identified 3 key themes to summarize the capital markets and SPAC trends this past month: 1. Soft Landing Optimism Still Intact 2. New Issue Market Overview – Seasonality & Volatility Dampen IPO Supply 3. SPAC Market Overview – SPAC Market Active on all Fronts CCM August Activity: CCM acted as Bookrunner on Black Spade Acquisition II Co's $150M IPO CCM is advising on 3 transactions that were announced in August: 1. USA Rare Earth, LLC and Inflection Point Acquisition Corp. II (IPXX) 2. Plum Acquisition Corp. III (PLMJ) and Tactical Resources Corp. 3. Concord Acquisition Corp II (CNDA) and Events.com CCM advised on 2 transactions that closed in August: 1. Armada Acquisition Corp. I and Rezolve AI (RZLV) 2. Moringa Acquisition Corp and Silexion Therapeutics Corp (SLXN) #capitalmarkets #IPOs #softlanding #SPACs #CCM

Listen to yesterday's Nasdaq TradeTalks panel on the current private market/private credit environment.   Speaking on 2024 outlook for private investing, Raphael Schorr shared, "we're currently experiencing a reset where (we believe) it will be an attractive time to deploy capital at lower entry multiples."   Watch the full panel here: https://lnkd.in/eQXJGHx4   #privatemarkets #privatecredit #investing #alternatives #privateequity #LMMP #VentureCapital

Are you anxious because the SENSEX has reached an all-time high? Are you considering WITHDRAWING your equity investments due to fears of a market correction? Or perhaps you’re contemplating INCREASING your equity investments, anticipating further market growth? Watch the video on our YouTube Channel before investing or withdrawing. https://lnkd.in/g9A-QYJj Share this with anyone unsure about what to do. ... We are AMFI registered Mutual Fund Distributors #Sensex #Nifty #Finance #Market #Election2024 #StockMarket #MutualFunds

Plexus Capital, LLC is excited to have two of our own Road Warriors: Cameron Coley (on the ISF Steering Committee) and Kevin Speight on the ground supporting the only community developed by and for independent sponsors to… The ISF Deal Series Chicago will take place on September 12 at the Hilton Chicago.  ➤ access and build relationships with vetted sources of capital through the ISF Deal Series, ➤ explore solutions and share best practices with peers in a candid, confidential environment, ➤ gain insights into proposed legislation, regulatory and policy changes that could materially impact your business ➤ source deals and stay connected to the latest industry trends ➤ enjoy access to the member directory of capital providers and independent sponsors members   Join a growing group of pre-vetted capital providers and independent sponsors already registered to attend! Learn more and request your invitation now! > https://lnkd.in/ewRq7juz Independent Sponsor Forum #IndependentSponsorForum #ISF #IndependentSponsors #Capital #CapitalProviders #Networking #PrivateEquity #PE #Deals #PEAdvisors #DealMaking #DealMakers #MiddleMarket #LowerMiddleMarket #Debt #DebtEquity

Conyers has advised Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology and aesthetics company focused on women’s health and breast reconstruction, in connection with its private placement of common shares and pre-funded warrants to certain institutional accredited investors. Pursuant to the securities purchase agreement, Establishment Labs agreed to sell two million common shares or, in lieu of common shares, pre-funded warrants at a price of US$25 per share. The aggregate gross proceeds from the offering before deducting related expenses are expected to be approximately US$50 million. Counsel Nicholas Kuria of Conyers’ BVI office advised on the transaction, working alongside O’Melveny & Myers LLP, New York. Read more here: https://loom.ly/DB_mEvU